President Biden says the U.S. will have supply for all adults by the end of May. Read More
Tag: Moderna
Moderna’s variant-specific COVID vaccine heads into trial, NIH reports
Enlarge / A vial of the current Moderna COVID-19 vaccine. (credit: Getty | Ivan Romano) Researchers have given out the first jabs of a tweaked version of Moderna’s COVID-19 vaccine, one aimed at fighting one of the most concerning coronavirus variants—the B.1.351 variant, first identified in South Africa. The jabs are part of an early […]
One-third of American adults have gotten a COVID vaccine. But not every state is doing a great job
President Biden says the U.S. will have supply for all adults by end of May. Read More
More NBA players are beginning to get vaccinated, which is what Kareem Abdul-Jabbar wanted weeks ago
We often discuss progress, but we’re seeing some in the NBA as it relates to vaccinations. Read more…
28.5% of American adults have gotten a COVID vaccine: How each U.S state is doing
President Biden says the U.S. will have supply for all adults by end of May. Read More
With Johnson & Johnson in the mix, here’s how each U.S. state is doing with COVID vaccine distribution
Nearly 10% of U.S. adults are fully vaccinated. Read More
State-by-state map: Georgia and D.C. lag in COVID vaccine rollout
Biden says the U.S. will have supply for all adults by end of May. Read More
A 3rd shot? A new booster? Vaccine makers race to trials to beat variants
Enlarge / COVID-19 vaccine at a vaccination center in Madrid on Feb. 26, 2021. (credit: Getty | NurPhoto) With worrisome coronavirus variants seemingly emerging and spreading everywhere, lead vaccine makers are wasting no time in trying to get ahead of the growing threat. This week, Moderna and partners Pfizer and BioNTech announced they have kicked […]
How states are doing in the COVID vaccine rollout: Storm-battered Texas falls behind
Moderna and Pfizer say they’re stepping up production. Read More
Johnson & Johnson’s single-dose COVID-19 vaccine is 66% effective, lagging rivals
Johnson & Johnson’s long-awaited vaccine appears to protect against COVID-19 with just one shot – not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses. J&J said Friday that in the U.S. and seven other countries, the single-shot vaccine was 66% effective overall at preventing moderate […]